Skip to main content

Table 3 Incidence of AEs during PCT or PCRT according to CTCAE and Clavien-Dindo gradesa

From: Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy

 

CD0 group (n = 61)

CD1/2 group (n = 44)

CD3/4 group (n = 10)

Total (n = 115)

P Value

Anemia

    

0.099

     Grade 0

6 (5.2)

6 (5.2)

0 (0.0)

12 (10.4)

 

     Grade 1/2

48 (41.7)

27 (23.5)

6 (5.2)

81 (70.4)

 

     Grade 3/4

7 (6.1)

11 (9.6)

4 (3.5)

22 (19.1)

 

Leukopenia

   

0.326

     Grade 0

24 (20.9)

9 (7.8)

4 (3.5)

37 (32.2)

 

     Grade 1/2

21 (18.3)

21 (18.3)

3 (2.6)

45 (39.1)

 

     Grade 3/4

16 (13.9)

14 (12.2)

3 (2.6)

33 (28.7)

 

Neutropenia

   

0.244

     Grade 0

16 (13.9)

4 (3.5)

3 (2.6)

23 (20.0)

 

     Grade 1/2

19 (16.5)

16 (13.9)

3 (2.6)

38 (33.0)

 

     Grade 3/4

26 (22.6)

24 (20.9)

4 (3.5)

54 (47.0)

 

Febrile neutropenia

   

0.829

     Grade 0

49 (42.6)

35 (30.4)

9 (7.8)

93 (80.9)

 

     Grade 3/4

12 (10.4)

9 (7.8)

1 (0.9)

22 (19.1)

 

Lymphocytopenia

   

0.748

     Grade 0

10 (8.7)

9 (7.8)

2 (1.7)

21 (18.3)

 

     Grade 1/2

41 (35.7)

29 (25.2)

5 (4.3)

75 (65.2)

 

     Grade 3/4

10 (8.7)

6 (5.2)

3 (2.6)

19 (16.5)

 

Thrombocytopenia

   

0.798

     Grade 0

39 (33.9)

26 (22.6)

8 (7.0)

73 (63.5)

 

     Grade 1/2

19 (16.5)

16 (13.9)

2 (1.7)

37 (32.2)

 

     Grade 3/4

3 (2.6)

2 (1.7)

0 (0.0)

5 (4.3)

 

Increased ALT/AST

 

0.718

     Grade 0

34 (29.6)

28 (24.3)

6 (5.2)

68 (59.1)

 

     Grade 1/2

27 (23.5)

16 (13.9)

4 (3.5)

47 (40.9)

 

Increased Scr

   

1.000

     Grade 0

58 (50.4)

41 (35.7)

9 (7.8)

108 (93.9)

 

     Grade 1/2

3 (2.6)

3 (2.6)

1 (0.9)

7 (6.1)

 

Total AEs

 

0.138

     Grade 0

0 (0.0)

1 (0.9)

0 (0.0)

1 (0.9)

 

     Grade 1/2

29 (25.2)

11 (9.6)

3 (2.6)

43 (37.4)

 

     Grade 3/4

32 (27.8)

32 (27.8)

7 (6.1)

71 (61.7)

 
  1. AEs adverse events, ALT alanine transaminase, AST aspartate transaminase, CTCAE common terminology criteria for adverse events, PCRT preoperative chemoradiotherapy, PCT preoperative chemotherapy, Scr serum creatinine
  2. aData are presented as number (incidence)